 |
|
 |
|
Myeloid malignancy
Article watch:
|
 |
Summaries of key papers selected by the editors.
|
|
Review watch:
|
 |
BloodMed exclusives:
|
 |
 |
 |
The best reviews from the journals. |
| |
|
|
|
|
Peer-reviewed articles summarizing hot topics, written
specially for BloodMed.com:
- Nilotinib in Chronic Myeloid Leukaemia
Kara K Melchizedek, Heather G Jørgensen, Tessa L Holyoake
- Immunophenotypic monitoring of residual disease in AML
Sylvie Freeman, Clinical Immunology, Division of Infection and Immunology, University of Birmingham, Birmingham, UK
- Core-binding factor acute myeloid leukemias - time for targeted therapy
Professor J T Reilly, Dept of Hematology, Royal Hallamshire Hospital, Sheffield
|
|
 |
 |
|
Specialist journals:
|
 |
Guideline watch:
|
 |
 |
|
Subspecialty journals by impact factor:
|
|
|
Current clinical guidelines.
- Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations
Tiziano Barbui, Giovanni Barosi, Gunnar Birgegard et al. European LeukemiaNet.
Journal of Clinical Oncology : official journal of the American Society of Clinical Oncology (2011): 1-10
- Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference.
Giovanni Barosi, Gunnar Birgegard, Guido Finazzi et al. European LeukemiaNet Blood (2009); Vol 113, Issue: 20: 4829-33
- Diagnosis and management of acute myeloid leukemia in adults.
Recommendations from an international expert panel, on behalf of the European LeukemiaNet.Hartmut Döhner, Elihu H Estey, Sergio Amadori, Frederick R Appelbaum, Thomas Büchner, Alan K Burnett, et al. Blood (2010); 115, Issue: 3, Pages: 453-474
|
|
|
Slide atlas:
|
| Latest additions to our slide collection |
|
| |
|
 |
|
 |